Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2014
09/25/2014US20140288161 Urocortin-iii and uses thereof
09/25/2014US20140288114 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
09/24/2014EP2781595A1 Method for proliferating stem cells by activating c-MET/HGF signalling
09/24/2014EP2781521A1 Novel spiroindoline compound, and medicinal agent comprising same
09/24/2014EP2781518A2 Fluorine-containing 5-[2-(pyrid-3-yl)-ethyl]-2,3,4-tetrahydro-1h-pyrido[4,3-b]indoles as agents for reducing uncontrolled protein aggregation
09/24/2014EP2781517A1 Nitrogenated heterocyclic compound
09/24/2014EP2781513A1 Benzofuran derivatives
09/24/2014EP2780376A1 Methods and products for increasing frataxin levels and uses thereof
09/24/2014EP2780328A1 N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/24/2014EP2780324A1 Heterocyclic carboxamides useful as inhibitors of phosphodiesterase type 10a
09/24/2014EP2780321A1 Mono-fluoro beta-secretase inhibitors
09/24/2014EP2780316A1 Esters of dcpla and methods of treatment using the same
09/24/2014EP2780082A1 Compositions and methods for treating alzheimer's disease
09/24/2014EP2780027A1 Apoaequorin for reducing neuronal injury due to ischemia
09/24/2014EP2780015A1 Muscarinic m1 receptor agonists
09/24/2014EP2780006A1 Composition for transdermal administration of rivastigmine
09/23/2014US8841254 Method for treatment of anxiety
09/23/2014CA2782347C Quinoline amide m1 receptor positive allosteric modulators
09/23/2014CA2720112C Suture line administration technique using botulinum toxins
09/23/2014CA2647417C Buprenorphine derivatives and uses thereof
09/23/2014CA2608153C Thiazole derivatives for use as p13k modulators
09/23/2014CA2602968C Crystals of morphinan derivative and process for producing the same
09/23/2014CA2596393C 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase for the treatment of anxiety, pain and other conditions
09/23/2014CA2588908C Induction of neurogenesis and stem cell therapy in combination with copolymer 1
09/23/2014CA2575341C Trpv1 agonists, formulations containing them and uses thereof
09/23/2014CA2548917C Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
09/23/2014CA2544332C Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
09/18/2014WO2014146082A1 Materials and methods for treating neuropathies and related disorders including those involving a keystone nerve
09/18/2014WO2014146069A1 Inhibition of central nervous system effects from smoking and sensory effects from smoking
09/18/2014WO2014146059A1 Halogenopyrazoles as inhibitors of thrombin
09/18/2014WO2014146044A1 Administration of nicotinamide mononucleotide in the treatment of disease
09/18/2014WO2014145316A1 Methods for identifying neuroprotective pkc activators
09/18/2014WO2014145118A1 Resorufin derivatives for treatment of oxidative stress disorders
09/18/2014WO2014144765A1 Seaweed extracts, unsaturated aldehydes, and methods of treatment
09/18/2014WO2014144654A1 Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
09/18/2014WO2014144512A1 Rapid disperse dosage form containing levetiracetam
09/18/2014WO2014144426A1 Methods of monitoring for adherence to aripiprazole therapy
09/18/2014WO2014144409A1 Optogenetic control of behavioral state
09/18/2014WO2014144342A1 Non-peptide bdnf neurotrophin mimetics
09/18/2014WO2014144330A1 Use of growth hormone or growth hormone receptor agonists to prevent or treat stress-sensitive psychiatric illness
09/18/2014WO2014144231A1 Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
09/18/2014WO2014144115A1 Fixed dose combination treatment for schizophrenia
09/18/2014WO2014144027A1 Tamper resistant pharmaceutical formulations
09/18/2014WO2014143992A1 Treating lysosomal storage disease
09/18/2014WO2014143990A1 Preparations derived from placental materials of making and using same
09/18/2014WO2014143985A1 Non-peptide bdnf neurotrophin mimetics
09/18/2014WO2014143666A1 Hdac inhibitors
09/18/2014WO2014143646A1 Pharmaceutical composition of s-ketamine hydrochloride
09/18/2014WO2014143579A1 Tetrahydropyrrolothiazine compounds
09/18/2014WO2014143380A1 Extended-release topiramate capsules
09/18/2014WO2014143201A1 Method for noribogaine treatment of addiction in patients on methadone
09/18/2014WO2014143146A1 Methods of administering monomethyl fumarate
09/18/2014WO2014142550A1 Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same
09/18/2014WO2014142549A1 Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same
09/18/2014WO2014142548A1 Phenyl carbamate compound and a composition for preventing or treating a nerve gas-induced disease comprising the same
09/18/2014WO2014142547A1 Phenyl carbamate compound and a composition for neuroprotection comprising the same
09/18/2014WO2014142520A1 Phenyl carbamate compounds for use in preventing or treating epilepsy or epilepsy-related syndrome
09/18/2014WO2014142519A1 Phenyl alkyl carbamate compounds for use in preventing or treating epilepsy or epilepsy-related syndrome
09/18/2014WO2014142518A1 Phenyl carbamate compounds for use in preventing or treating a movement disorder
09/18/2014WO2014142477A1 Phenyl carbamate compounds for use in preventing or treating pediatric epilesy and epilesy-related syndromes
09/18/2014WO2014142322A1 Benzothiophene derivative
09/18/2014WO2014142290A1 Pyrazole-amide compound and medicinal uses therefor
09/18/2014WO2014142276A1 4-hydroperoxy-trans-2-decenoic acid derivative and medicine containing same
09/18/2014WO2014142255A1 Heterocyclic compound
09/18/2014WO2014141280A1 Methods, compositions and devices for treatment of motor and depression symptoms associated with parkinson's disease
09/18/2014WO2014141265A1 Inhibition of neurodegenerative disease by grape seed extract, green tea extract and probiotic bacteria
09/18/2014WO2014141261A1 Method for treatment of parkinson's disease
09/18/2014WO2014141219A1 Umbilical cord blood derived stem cell transplantation for the treatment of neural disorder
09/18/2014WO2014141091A1 Pyrrole derivatives as alpha 7 nachr modulators
09/18/2014WO2014141065A1 Azetidine amide derivatives as orexin receptor antagonists
09/18/2014WO2014140510A1 Pro-drug compounds
09/18/2014WO2014140313A1 Macrocyclic salt-inducible kinase inhibitors
09/18/2014WO2014140310A1 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/18/2014WO2014140279A1 Novel inhibitors
09/18/2014WO2014140246A1 Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine d3 receptor
09/18/2014WO2014140235A1 Macrocyclic lrrk2 kinase inhibitors
09/18/2014WO2014140186A1 Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases
09/18/2014WO2014140184A1 Novel inhibitor compounds of phosphodiesterase type 10a
09/18/2014WO2014140086A1 Novel inhibitor compounds of phosphodiesterase type 10a
09/18/2014WO2014139882A1 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
09/18/2014WO2014139681A1 Crystalline cis-(e)-4-(3-fluorophenyl)-2',3',4',9'-tetrahydro-n,n-dimethyl-2'-(1-oxo-3-phenyl-2-propenyl)-spiro[cyclohexane-1,1'[1h]-pyrido[3,4-b]indol]-4-amine
09/18/2014WO2014139458A1 Fused ring compound containing pyrimidine or pyridine and use thereof as anti-tumour drug
09/18/2014WO2014139443A1 Low immunogenicity human cell and preparation method therefor
09/18/2014WO2014139318A1 Application of phthalide compound
09/18/2014WO2014139227A1 Lump sugar, and production method and application thereof
09/18/2014WO2014139161A1 Novel high penetration drugs and their compositions thereof for treatment of parkinson diseases
09/18/2014WO2014139150A1 Substituted pyridizinone derivatives as pde10 inhibitors
09/18/2014WO2014138814A1 S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis
09/18/2014WO2014138812A1 Salts, co-crystals, and polymorphs of an anxiolytic compound
09/18/2014WO2014138791A1 Transgenic non-human organisms with non-functional tspo genes
09/18/2014WO2014138772A1 A crystalline form of an anxiolytic compound
09/18/2014WO2013100571A9 Phenyl carbamate compounds for use in preventing or treating als
09/18/2014US20140275618 Therapeutic compounds and methods of use
09/18/2014US20140275545 8-carboxamido-2,6-methano-3-benzazocines
09/18/2014US20140275225 Modulators of pharmacological agents
09/18/2014US20140275115 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
09/18/2014US20140273074 Yeast screens for treatment of human disease
09/18/2014US20140271799 Transdermal administration of fentanyl and analogs thereof
09/18/2014US20140271637 Methods of administering anti-tnfalpha antibodies
09/18/2014US20140271541 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 1833